MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS)
Clinical trials for MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS) explained in plain language.
Never miss a new study
Get alerted when new MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS) trials appear
Sign up with your email to follow new studies for MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New ultrasound device could replace MRI for liver fat checks
Diagnosis Recruiting nowThis study tests a new device that uses sound waves to measure fat in the liver. About 49 adults will get a scan with this device and then an MRI to see if the results match. The goal is to create a simpler, more accessible way to check liver fat, which is important for overall h…
Matched conditions: MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS)
Sponsor: Endra Lifesciences • Aim: Diagnosis
Last updated May 19, 2026 11:48 UTC
-
Gene hunt: could your DNA predict fatty liver risk?
Knowledge-focused Recruiting nowThis study looks at how certain gene changes (PNPLA3) affect fatty liver disease in 600 adults from Guadeloupe, French Guiana, and Réunion Island. Researchers will collect blood samples to find which gene versions are common and how they relate to liver damage. The goal is to bet…
Matched conditions: MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS)
Sponsor: Centre Hospitalier Universitaire de la Guadeloupe • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC
-
Cancer survivors face hidden liver risk – new study aims to catch it early
Knowledge-focused Recruiting nowThis study looks at why breast and colorectal cancer survivors may be at higher risk for a common liver condition called MASLD (fatty liver disease). Researchers will use painless ultrasound and MRI scans, along with blood tests, to detect liver damage early. The goal is to impro…
Matched conditions: MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS)
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated May 19, 2026 11:46 UTC